{"id":612033,"date":"2022-08-16T13:10:02","date_gmt":"2022-08-16T13:10:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=612033"},"modified":"2022-08-16T13:10:02","modified_gmt":"2022-08-16T13:10:02","slug":"interventional-cardiology-and-peripheral-vascular-device-market-is-expected-to-reach-316-billion-by-2027-an-exclusive-market-research-report-by-lucintel","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/interventional-cardiology-and-peripheral-vascular-device-market-is-expected-to-reach-316-billion-by-2027-an-exclusive-market-research-report-by-lucintel_612033.html","title":{"rendered":"Interventional Cardiology and Peripheral Vascular Device Market is expected to reach $31.6 Billion by 2027 &#8211; An exclusive market research report by Lucintel"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1660631868.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\" Interventional Cardiology and Peripheral Vascular Device Market is expected to reach $31.6 Billion by 2027 - An exclusive market research report by Lucintel\" src=\"https:\/\/www.abnewswire.com\/uploads\/1660631868.jpeg\" alt=\" Interventional Cardiology and Peripheral Vascular Device Market is expected to reach $31.6 Billion by 2027 - An exclusive market research report by Lucintel\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Trends and Forecast for the Global Interventional Cardiology And Peripheral Vascular Device Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Trends, opportunities and forecast in interventional cardiology and peripheral vascular device market to 2027 by type (interventional cardiology and peripheral vascular device), device (angioplasty balloons, angioplasty stents, angioplasty catheters, EVAR stent graft, IVC filter, embolic protection device, guidewires, arteriotomy closure device, intravascular ultrasound system, and synthetic surgical graft), end user (hospitals and ambulatory surgical centers), and region (North America, Europe<\/div>\n<p style=\"text-align: justify;\">Lucintel&#8217;s latest market report analyzed that <a rel=\"nofollow\" href=\"https:\/\/www.lucintel.com\/interventional-cardiology-peripheral-vascular-devi.aspx\">interventional cardiology and peripheral vascular device<\/a> provides attractive opportunities in hospitals and ambulatory surgical centers. The interventional cardiology and peripheral vascular device market is expected to reach $31.6 billion by 2027 with a CAGR of 5.7%. In this market, interventional cardiology devices is the largest segment by type, whereas hospitals is largest by end user. Rising adoption of TAVR procedure, increasing use of bioresorbable stents, and rising adoption of drug eluting balloons provides strategic growth path in this market.<\/p>\n<p style=\"text-align: justify;\"><strong>Download Brochure<\/strong> of this report by clicking on <a rel=\"nofollow\" href=\"https:\/\/www.lucintel.com\/interventional-cardiology-peripheral-vascular-devi.aspx\">https:\/\/www.lucintel.com\/interventional-cardiology-peripheral-vascular-devi.aspx<\/a> Based on type, the interventional cardiology and peripheral vascular device market is segmented into interventional cardiology and peripheral vascular device. The interventional cardiology devices segment accounted for the largest share of the market in 2021 and is expected to register the highest CAGR during the forecast period.<\/p>\n<p style=\"text-align: justify;\">Browse in-depth TOC on &ldquo;Interventional Cardiology and Peripheral Vascular Device Market&rdquo;<\/p>\n<p style=\"text-align: justify;\">97 &ndash; Tables<\/p>\n<p style=\"text-align: justify;\">112 &ndash; Figures<\/p>\n<p style=\"text-align: justify;\">201 &ndash; Pages<\/p>\n<p style=\"text-align: justify;\">The Interventional Cardiology and Peripheral Vascular Device Market is marked by the presence of several big and small players. Some of the prominent players offering interventional cardiology and peripheral vascular device include Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronics Public Limited Company, C. R. Bard, Inc., Cook Medical Inc., Terumo Corporation, and Cardinal Health Inc.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Report:<\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.lucintel.com\/interventional-cardiology-peripheral-vascular-devi.aspx\">https:\/\/www.lucintel.com\/interventional-cardiology-peripheral-vascular-devi.aspx<\/a><\/p>\n<p style=\"text-align: justify;\">This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.<\/p>\n<p style=\"text-align: justify;\"><strong>About Lucintel<\/strong><\/p>\n<p style=\"text-align: justify;\">Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&amp;A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit <a rel=\"nofollow\" href=\"http:\/\/www.lucintel.com\/\">www.lucintel.com<\/a>.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/lucintel.com_72979.html\" rel=\"nofollow\">Lucintel<\/a><br \/><strong>Contact Person:<\/strong> Brandon Fitzgerald<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=interventional-cardiology-and-peripheral-vascular-device-market-is-expected-to-reach-316-billion-by-2027-an-exclusive-market-research-report-by-lucintel\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 303.775.0751<br \/><strong>Address:<\/strong>8951 Cypress Waters Blvd.,  Suite 160<br \/><strong>City:<\/strong> Dallas<br \/><strong>State:<\/strong> TEXAS<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.lucintel.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.lucintel.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.lucintel.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=interventional-cardiology-and-peripheral-vascular-device-market-is-expected-to-reach-316-billion-by-2027-an-exclusive-market-research-report-by-lucintel\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Trends and Forecast for the Global Interventional Cardiology And Peripheral Vascular Device Market Trends, opportunities and forecast in interventional cardiology and peripheral vascular device market to 2027 by type (interventional cardiology and peripheral vascular device), device (angioplasty balloons, angioplasty stents, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/interventional-cardiology-and-peripheral-vascular-device-market-is-expected-to-reach-316-billion-by-2027-an-exclusive-market-research-report-by-lucintel_612033.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[418,421,402,429,440],"tags":[],"class_list":["post-612033","post","type-post","status-publish","format-standard","hentry","category-Building-Construction","category-Computers-Software","category-Food-Beverage","category-Hospitality","category-Real-Estate"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/612033","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=612033"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/612033\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=612033"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=612033"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=612033"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}